Identifying liver cirrhosis in patients with chronic hepatitis B: an interpretable machine learning algorithm based on LSM

被引:0
|
作者
Bai, Xueting [1 ]
Pu, Chunwen [2 ]
Zhen, Wenchong [1 ]
Huang, Yushuang [2 ]
Zhang, Qian [1 ]
Li, Zihan [1 ]
Zhang, Yixin [1 ]
Xu, Rongxuan [1 ]
Yao, Zhihan [1 ]
Wu, Wei [1 ]
Sun, Mei [2 ]
Li, Xiaofeng [1 ]
机构
[1] Dalian Med Univ, Dept Epidemiol & Hlth Stat, 9 West Sect Lvshun Rd, Dalian, liaoning, Peoples R China
[2] Dalian Publ Hlth Clin Ctr, Dalian, Liaoning, Peoples R China
关键词
Chronic hepatitis B; liver cirrhosis; machine learning; liver stiffness measurement; diagnostic model; STIFFNESS MEASUREMENT; FIBROSIS; DIAGNOSIS; FIB-4;
D O I
10.1080/07853890.2025.2477294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundChronic hepatitis B (CHB) is a common cause of liver cirrhosis (LC), a condition associated with an unfavourable prognosis. Therefore, timely diagnosis of LC in CHB patients is crucial.ObjectiveThis study aimed to enhance the diagnostic accuracy of LC in CHB patients by integrating liver stiffness measurement (LSM) with traditional indicators.MethodsThe study participants were randomly divided into training and internal validation sets. Employing the least absolute shrinkage and selection operator (LASSO) and random forest-recursive feature elimination (RF-RFE) for feature selection, we developed both traditional logistic regression and five machine learning models (k-nearest neighbors, random forest (RF), artificial neural network, support vector machine and eXtreme Gradient Boosting). Performance evaluation included receiver operating characteristic curves, calibration curves and decision curve analysis. Shapley additive explanations (SHAP) was employed to improve the interpretability of the optimal model.ResultsWe retrospectively included 1609 patients with CHB, among whom 470 were diagnosed with cirrhosis. Cirrhosis was diagnosed based on histological confirmation or clinical assessment, supported by characteristic findings on abdominal ultrasound and corroborative evidence such as thrombocytopenia, varices or imaging from CT/MRI. In the internal validation, the RF model achieved an accuracy above 0.80 and an AUC above 0.80, with outstanding calibration ability and clinical net benefit. Additionally, the model exhibited excellent predictive performance in an independent external validation set. The SHAP analysis indicated that LSM contributed the most to the model. The model still showed strong discriminative power when using only LSM or traditional indicators alone.ConclusionsMachine learning models, especially the RF model, can effectively identify LC in CHB patients. Integrating LSM with traditional indicators can enhance diagnostic performance.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Correlation of Liver Stiffness and Histological Features in Healthy Persons and in Patients With Occult Hepatitis B, Chronic Active Hepatitis B, or Hepatitis B Cirrhosis
    Fung, James
    Lai, Ching -Lung
    Chan, See-Ching
    But, David
    Seto, Wai-Kay
    Cheng, Charles
    Wong, Danny Ka-Ho
    Lo, Chung-Mau
    Fan, Sheung-Tat
    Yuen, Man-Fung
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1116 - 1122
  • [32] Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
    Jiang, Chuan
    Xu, Zhenyu
    Liu, Jinqing
    Li, Ronghua
    Chen, Keyu
    Peng, Wenting
    Xiao, Yueming
    Cheng, Da
    Fu, Lei
    Peng, Shifang
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [33] Improved prediction for liver fibrosis of Fibrosis-4 using machine learning in patients with chronic hepatitis B
    Zhang, Zhiyi
    Wang, Jian
    Zhang, Shaoqiu
    Pan, Yifan
    Zhu, Li
    Li, Yiguang
    Ding, Weimao
    Li, Jie
    Qiu, Yuanwang
    Huang, Rui
    Wu, Chao
    Zhu, Chuanwu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1068 - S1069
  • [34] Predicting Hepatitis B to be acute or chronic in an infected person using machine learning algorithm
    Vijayalakshmi, C.
    Mohideen, S. Pakkir
    ADVANCES IN ENGINEERING SOFTWARE, 2022, 172
  • [35] Antiviral therapy in patients with chronic hepatitis B and cirrhosis
    Lai, CJ
    Terrault, NA
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 629 - +
  • [36] Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients
    Hu, Yu-Wen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1655 - 1655
  • [37] Accuracy of liver stiffness measurement (LSM) for the diagnosis of cirrhosis in patients with chronic liver diseases (CLD):: A study in 1345 patients
    Ganne-Carrié, N
    de Lédinghen, V
    Douvin, C
    Marcellin, P
    Castera, L
    Ziol, M
    Beaugrand, M
    HEPATOLOGY, 2005, 42 (04) : 338A - 338A
  • [38] LIVER STIFFNESS AND HISTOLOGICAL FEATURES IN HEALTHY PERSONS, AND PATIENTS WITH OCCULT HEPATITIS B, CHRONIC ACTIVE HEPATITIS B, AND HEPATITIS B-RELATED CIRRHOSIS
    Fung, James
    Lai, Ching-Lung
    Chan, See-Ching
    But, David
    Seto, Walter Wai Kay
    Cheng, Charles
    Wong, Danny
    Lo, Chung-Mau
    Fan, Sheung Tat
    Yuen, Man-Fung
    HEPATOLOGY, 2009, 50 (04) : 978A - 979A
  • [39] HBXAG IN THE LIVER FROM CARRIER PATIENTS WITH CHRONIC HEPATITIS AND CIRRHOSIS
    WANG, WL
    LONDON, WT
    LEGA, L
    FEITELSON, MA
    HEPATOLOGY, 1991, 14 (01) : 29 - 37
  • [40] Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis
    Kawasaki, T
    Takeshita, A
    Souda, K
    Kobayashi, Y
    Kikuyama, M
    Suzuki, F
    Kageyama, F
    Sasada, Y
    Shimizu, E
    Murohisa, G
    Koide, S
    Yoshimi, T
    Nakamura, H
    Ohno, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (07): : 1918 - 1922